WAYNE GOODMAN to Piperazines
This is a "connection" page, showing publications WAYNE GOODMAN has written about Piperazines.
Connection Strength
0.178
-
m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation. Biol Psychiatry. 1995 Aug 01; 38(3):138-49.
Score: 0.111
-
Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder. Psychiatry Res. 1999 Mar 22; 85(3):225-40.
Score: 0.036
-
Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology (Berl). 1987; 92(1):14-24.
Score: 0.015
-
The serotonin hypothesis of obsessive compulsive disorder. Int Clin Psychopharmacol. 1993 Nov; 8 Suppl 2:79-82.
Score: 0.006
-
The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J Clin Psychiatry. 1992 Apr; 53 Suppl:17-28.
Score: 0.006
-
Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry. 1988 Feb; 45(2):177-85.
Score: 0.004